Skip to main content
Caplight Logo









NeuroLeap

NeuroLeap

Private
MumbaiHealthcare & Life Scienceshttps://www.neuroleap.science/

Last Round

Accelerator

Jan 10, 2022

Momentum

Top 50%

of companies Caplight tracks

Company Overview

NeuroLeap is a health technology company that provides brain assessment and enhancement services using non-invasive brain-computer interface technology.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Medical Devices, Healthcare Analytics

Business Model

B2C

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

brain-computer interfaceBCIneurofeedbackneuro-mappingcognitive performancebrain trainingmental health supportbiohackingcognitive enhancementbrain function assessmentstress managementnon-invasive diagnosticsbrain healthwellness clinic

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NeuroLeap Comparables

Compare NeuroLeap with similar companies based on industry and business-model similarity.

NeuroLeap comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Peak Brain Institute
82%
Sens.ai Incorporated
72%
PankhTech India Private Limited
68%

NeuroLeap Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJan 10, 2022
AngelOct 9, 2019

NeuroLeap Investors

Notable investors and investment history

NeuroLeap investors
InvestorRounds
N. S. Raghavan Centre for Entrepreneurial LearningAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 214% MoM, reaching 4.4K.

  • May 16, 2026

    Monthly visitors increased 31% MoM.

NeuroLeap Filings

Explore SEC and related filing metadata, where available.

NeuroLeap filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NeuroLeap's valuation, stock price, and market status.

Is NeuroLeap a public or private company?

NeuroLeap is a private company.

What is the current stock price of NeuroLeap?

NeuroLeap is a private company with no public stock price. No recent secondary market data is available.

How much is NeuroLeap worth (valuation)?

Valuation information for NeuroLeap is not publicly available.

Can I buy NeuroLeap stock?

NeuroLeap shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was NeuroLeap's last funding round?

NeuroLeap's most recent funding round was Accelerator on January 10, 2022.

Who are the main investors in NeuroLeap?

Key investors in NeuroLeap include N. S. Raghavan Centre for Entrepreneurial Learning.

Will NeuroLeap IPO soon?

No public IPO plans have been announced for NeuroLeap.

How can I track NeuroLeap secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NeuroLeap's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMumbai
Employee Range8
Year Founded2017
Last FundingJan 10, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?